Elijaid – Articles Page
Aburaihan Pharmaceutical Company
Product Information
Approval Package
| 1 | Jadenu - Drug Approval Package - Summary Review | EN | FDA | Download |
| 2 | Jadenu - Drug Approval Package - Cross Discipline Team Leader Review | EN | FDA | Download |
| 3 | Jadenu - Drug Approval Package - Medical Review | EN | FDA | Download |
| 4 | Jadenu - Drug Approval Package - Chemistry Review | EN | FDA | Download |
| 5 | Jadenu - Drug Approval Package - Pharmacology Review | EN | FDA | Download |
| 6 | Jadenu - Drug Approval Package - Microbiology Review | EN | FDA | Download |
| 7 | Jadenu - Drug Approval Package - Clinical Pharmacology Biopharmaceutics Review | EN | FDA | Download |
| 8 | Jadenu - Drug Approval Package - Proprietary Name Review(s) | EN | FDA | Download |
| 9 | Jadenu - Drug Approval Package - Other Review(s) | EN | FDA | Download |
| 10 | Jadenu - Drug Approval Package - Administrative Document(s) & Correspondence | EN | FDA | Download |
Review Article
| 1 | Deferasirox for managing iron overload in people with thalassaemia | 2012 | EN | Cochrane | Download |
| 2 | Deferasirox for managing iron overload in people with thalassaemia | 2017 | EN | Cochrane | Download |
| 3 | Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia | 2016 | EN | Cochrane | Download |
| 4 | Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia | 2018 | EN | Cochrane | Download |
Original Research
| 1 |
Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs Deferiprone and Deferasirox |
2018 | EN | PLOS ONE | Download |
| 2 |
Patient-reported outcomes from a randomized phase II study of the Deferasirox film-coated tablet in patients with transfusion-dependent anemias - Health and Quality of Life Outcomes |
2018 | EN | Health and Quality of Life Outcomes | Download |
| 3 |
Influence of patient‐reported outcomes on the treatment effect of Deferasirox film‐coated and dispersible tablet formulations in the ECLIPSE trial A post hoc mediation analysis |
2019 | EN | Am J Hematol | Download |